News

Race Oncology appoints Associate Professor Erin Howden to scientific advisory board Howden has researched adverse effects of chemotherapy on cardiovascular fitness of cancer patients Appointment aims to bring Race Oncology’s…

Race Oncology Ltd (ASX:RAC, OTC:RAONF) CEO Daniel Tillett joins Jonathan Jackson in the Proactive studio to provide an update on the company’s movements over the last few months. Just recently, Race received a…

Leading cardiologist says bisantrene has potential to significantly change cancer treatment landscape Bisantrene could minimise damage to the heart linked to many cancer therapies New CEO is prioritising swift delivery…

2024 Preview: Race Oncology (ASX:RAC) from Stockhead on Vimeo. Stockhead’s Ashtyn Hiron sits down with Race Oncology (ASX:RAC) CEO Daniel Tillett to close the books on 2023 and gain a sneak peek…

The Race Oncology Annual General Meeting was held on Monday 27 November 2023. During the meeting the Race Board and management team provided an update on the forward-looking strategy, detailed…